Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Leonard

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|April 1, 1991
Primary systemic therapy for operable breast cancerE D Anderson, A P Forrest, R A Hawkins, et al.
British Journal of Cancer|July 1, 1993
The prognostic value of early CA125 serum assay in epithelial ovarian carcinomaJ Fisken, R C Leonard, M Stewart, et al.
British Journal of Cancer|May 1, 1993
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125J Fisken, J E Roulston, C Sturgeon, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Disease Markers|December 1, 1993
Serological markers for metastatic breast cancerJ S Ng, C M Sturgeon, J Seth, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patientsS S Akhtar, S G Allan, A Rodger, et al.
British Journal of Cancer|January 1, 1992
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinomaD M Eccles, L Brett, A Lessells, et al.
British Journal of Cancer|January 1, 1983
Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classificationR C Leonard, J Cuzick, I C MacLennan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screeningC D Love, B B Muir, J B Scrimgeour, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|April 1, 1991
Primary systemic therapy for operable breast cancerE D Anderson, A P Forrest, R A Hawkins, et al.
British Journal of Cancer|July 1, 1993
The prognostic value of early CA125 serum assay in epithelial ovarian carcinomaJ Fisken, R C Leonard, M Stewart, et al.
British Journal of Cancer|May 1, 1993
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125J Fisken, J E Roulston, C Sturgeon, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Disease Markers|December 1, 1993
Serological markers for metastatic breast cancerJ S Ng, C M Sturgeon, J Seth, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patientsS S Akhtar, S G Allan, A Rodger, et al.
British Journal of Cancer|January 1, 1992
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinomaD M Eccles, L Brett, A Lessells, et al.
British Journal of Cancer|January 1, 1983
Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classificationR C Leonard, J Cuzick, I C MacLennan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screeningC D Love, B B Muir, J B Scrimgeour, et al.
Pageof 18